Press Releases

Duke Street Bio Announces First Patient Dosed in Phase I Trial with DSB2455, a Next Generation PARP1 Selective Inhibitor for the Treatment of Solid Tumours

Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.

2BScientific Limited announces opening of a new European hub in Germany

2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and broadening the reach of its existing suppliers.

Cold Chain Technologies Acquires Tower Cold Chain, Expanding its Product Portfolio and Global Service Network

Huateng Pharma Provides PEG-Based Hydrogels for Medical Device Applications

Clinion Wins SCDM 2024 Innovation Award for Excellence in Clinical Data Science

Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.

India Charts BioE3 Policy to Propel Advanced Biomanufacturing

The government announced the BioE3 (Biotechnology for Economy, Environment and Employment) policy, a strategic plan to take India to the next era of industrialization through advanced biomanufacturing. Enhancing India’s biomanufacturing capabilities by integrating science, technology, engineering, and manufacturing will enable institutions, universities, startups, and industries in India to participate in innovation, thereby supporting the growth of the upstream bioprocessing market.

Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development

PhaseV's Machine Learning Platforms are Being Used by Top Global Pharma Companies to Guide Adaptive Trials, Precision Medicine, and Indication Selection Across Multiple Therapeutic Areas

Hovione Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland

Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.

eClinical Solutions Positioned as Highest Leader in Everest Group’s Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024

Industry recognition highlights company’s diverse portfolio mix, flexibility and ease of deployment, and data integration capabilities, driving real-time review and insights

CIRCOR’s Highlights BB PEP Series Pumps for Polymer Extrusion

CIRCOR International, Inc., a leading manufacturer and marketer of differentiated technology products and sub-systems, highlights its new BB PEP Series pumps, engineered for high-precision performance in polymer extrusion applications. With a focus on consistent, accurate performance, the BB PEP Series addresses critical demands such as uniformity, durability, and ease of maintenance in the chemical, industrial and life sciences industries.

Beta Bionics Secures $60 Million in Series E Funding to Advance Diabetes Care Innovations

In November 2024, a $60 million fundraising transaction for Series E preferred stock was successfully closed by Beta Bionics, Inc., a trailblazing leader in the creation of cutting-edge diabetes treatment solutions.

Illumina Rolls out MiSeq i100 Series to Reshape Next-Generation Sequencing

The MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.

Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses

Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.

City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics

City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.

Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.

Greenphire Appoints Product Management Expert Derek Bluestone as New Chief Product Officer

Greenphire, a leading innovator in software solutions for improving clinical research site performance and participant satisfaction, announced the addition of product strategy expert Derek Bluestone as its new CPO.

Kindeva Drug Delivery Appoints New CIO to Lead Digital Transformation Business Initiatives

Gifthealth Announces Strategic Partnership with United Digestive

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Oxford Nanopore and Wasatch BioLabs Announce Collaboration to Transform DNA Methylation Analysis with New dWMS Product

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.